Related references
Note: Only part of the references are listed.Evaluation of Cytotoxic, COX Inhibitory, and Antimicrobial Activities of Novel Isoxazole-carboxamide Derivatives
Mohammed Hawash et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2023)
A New Oxadiazole-Based Topsentin Derivative Modulates Cyclin-Dependent Kinase 1 Expression and Exerts Cytotoxic Effects on Pancreatic Cancer Cells
Camilla Pecoraro et al.
MOLECULES (2022)
Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification
Daniela Carbone et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design and synthesis of novel substituted indole-acrylamide derivatives and evaluation of their anti-cancer activity as potential tubulin-targeting agents
Mohammed Hawash et al.
JOURNAL OF MOLECULAR STRUCTURE (2022)
Molecular docking studies and biological evaluation of isoxazole-carboxamide derivatives as COX inhibitors and antimicrobial agents
Mohammed Hawash et al.
3 BIOTECH (2022)
Recent Advances of Tubulin Inhibitors Targeting the Colchicine Binding Site for Cancer Therapy
Mohammed Hawash
BIOMOLECULES (2022)
Gundelia tournefortii inhibits hepatocellular carcinoma progression by lowering gene expression of the cell cycle and hepatocyte proliferation in immunodeficient mice
Johnny Amer et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2
Kenji Masuo et al.
CANCER SCIENCE (2021)
Synthesis of new pyrazoles, oxadiazoles, triazoles, pyrrolotriazines, and pyrrolotriazepines as potential cytotoxic agents
Ameen Ali Abu-Hashem
JOURNAL OF HETEROCYCLIC CHEMISTRY (2021)
Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Novel Indolylacrylamide Derivatives: Synthesis and Biological Evaluation
Mohammed Hawash et al.
CHEMISTRY & BIODIVERSITY (2021)
Synthesis and Biological Evaluation of Novel Isoxazole-Amide Analogues as Anticancer and Antioxidant Agents
Ahmad M. Eid et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Cancer statistics for the year 2020: An overview
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Design, synthesis, and biological evaluation of phenyl-isoxazole-carboxamide derivatives as anticancer agents
Mohammed Hawash et al.
HETEROCYCLIC COMMUNICATIONS (2021)
Synthesis, chemo-informatics, and anticancer evaluation of fluorophenyl-isoxazole derivatives
Mohammed Hawash et al.
OPEN CHEMISTRY (2021)
PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA
Melissa F. Adasme et al.
NUCLEIC ACIDS RESEARCH (2021)
Dexamethasone Inhibits Spheroid Formation of Thyroid Cancer Cells Exposed to Simulated Microgravity
Daniela Melnik et al.
CELLS (2020)
Thiophene-based derivatives as anticancer agents: An overview on decade's work
Archna et al.
BIOORGANIC CHEMISTRY (2020)
A Review on Anticancer Activities of Thiophene and Its Analogs
Raghav Mishra et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)
Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line
Abdolkhaleg Deezagi et al.
MOLECULAR BIOLOGY REPORTS (2020)
Synthesis and Biological Evaluation of Benzodioxole Derivatives as Potential Anticancer and Antioxidant agents
Mohammed Hawash et al.
HETEROCYCLIC COMMUNICATIONS (2020)
Diarylthiazole and diarylimidazole selective COX-1 inhibitor analysis through pharmacophore modeling, virtual screening, and DFT-based approaches
Luminita Crisan et al.
STRUCTURAL CHEMISTRY (2019)
Carlina curetum plant phytoconstituents, enzymes inhibitory and cytotoxic activity on cervical epithelial carcinoma and colon cancer cell lines
Nidal Amin Jaradat et al.
EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE (2019)
Role of sulphur-heterocycles in medicinal chemistry: An update
Shelly Pathania et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Highlights on Specific Biological Targets; Cyclin-Dependent Kinases, Epidermal Growth Factor Receptors, Ras Protein, and Cancer Stem Cells in Anticancer Drug Development
Mohammed Hawash
DRUG RESEARCH (2019)
Relationship between tumour size and response to neoadjuvant chemotherapy among breast cancer patients in a tertiary center in Nigeria
Olatoke Samuel et al.
MALAWI MEDICAL JOURNAL (2018)
A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer
Chih-Yang Huang et al.
BIOMEDICINE-TAIWAN (2017)
Combretastatin-A4 phosphate improves the distribution and antitumor efficacy of albumin-bound paclitaxel in W256 breast carcinoma model
Meng Gao et al.
ONCOTARGET (2016)
Thiophene-expanded guanosine analogues of Gemcitabine
Zhe Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities
Samuel Genheden et al.
EXPERT OPINION ON DRUG DISCOVERY (2015)
Synthesis, characterization, and pharmacological evaluation of some novel thiadiazoles and thiazoles incorporating pyrazole moiety as anticancer agents
Sobhi M. Gomha et al.
MONATSHEFTE FUR CHEMIE (2015)
Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors
Sultan Nacak Baytas et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among US FDA Approved Pharmaceuticals
Edon Vitaku et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Synthesis of combretastatin A-4 O-alkyl derivatives and evaluation of their cytotoxic, antiangiogenic and antitelomerase activity
Sandra Torijano-Gutierrez et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Synthesis of ester and amide derivatives of 1-phenyl-3-(thiophen-3-yl)-1H-pyrazole-4-carboxylic acid and study of their anticancer activity
Nazan Inceler et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Synthesis, cytotoxicity, and molecular properties prediction of novel 1,3-diarylpyrazole derivatives
Sultan Nacak Baytas et al.
MEDICINAL CHEMISTRY RESEARCH (2013)
Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer
Paul Nathan et al.
CLINICAL CANCER RESEARCH (2012)
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
Hashem B. El-Serag
GASTROENTEROLOGY (2012)
Synthesis, molecular conformation, vibrational and electronic transition, isometric chemical shift, polarizability and hyperpolarizability analysis of 3-(4-Methoxy-phenyl)-2-(4-nitro-phenyl)-acrylonitrile: A combined experimental and theoretical analysis
Abdullah Mohamed Asiri et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2011)
Improved side-chain torsion potentials for the Amber ff99SB protein force field
Kresten Lindorff-Larsen et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Doxorubicin-Conjugated lmmuno-Nanoparticles for Intracellular Anticancer Drug Delivery
Meng Shi et al.
ADVANCED FUNCTIONAL MATERIALS (2009)
Hydrogen Bonding, Electrostatic Potential, and Molecular Design
Peter W. Kenny
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Benchmarking the reliability of QikProp. Correlation between experimental and predicted values
Leukothea Ioakimidis et al.
QSAR & COMBINATORIAL SCIENCE (2008)
In vitro metabolism study of combretastatin A-4 in rat and human liver Microsomes
Silvio Aprile et al.
DRUG METABOLISM AND DISPOSITION (2007)
Early effects of combretastatin-A4 disodium phosphate on tumor perfusion and interstitial fluid pressure
Carsten D. Ley et al.
NEOPLASIA (2007)
Novel combretastatin analogues endowed with antitumor activity
Daniele Simoni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Medicinal chemistry of combretastatin A4: Present and future directions
GC Tron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Tetra substituted thiophenes as anti-inflammatory agents: Exploitation of analogue-based drug design
AD Pillai et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Synthesis and antibacterial activity of 1-[1,2,4-triazol-3-yl] and 1-[1,3,4-thiadiazol-2-yl]-3-methylthio-6,7-dihydro-benzo[c]thiophen-4(5H)ones
S Tehranchian et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Phase I trial of the antivascular agent combretastatin A4 phosphate on a 5-day schedule to patients with cancer: Magnetic resonance imaging evidence for altered tumor blood flow
JP Stevenson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)